Powered by Google TranslateTranslate
Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Latest Press Releases
View all
TimeHeadline
32m agoEyebright Medical Releases Its 2025 Annual Report and Sustainability Report
32m agoThe Trade Desk Powers Open Internet Growth with DramaBox Short Drama Partnership
1h agoAscletis Completes Enrollment in U.S. Phase II Study of ASC30, an Oral Small Molecule GLP-1R Agonist, for the Treatment of Diabetes
2h agoSun Pharma signs Definitive Agreement to Acquire Organon
5h agoVeradermics to Hold Conference Call to Discuss Topline Results from Phase 2/3 ‘302’ Study of VDPHL01 in Males with Mild-to-Moderate Pattern Hair Loss
Whitehawk Therapeutics, Inc. logo

Whitehawk Therapeutics, Inc.

About

Whitehawk Therapeutics, Inc. (NASDAQ:WHWK) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 19 2026
Whitehawk Therapeutics Presents Comprehensive Preclinical Data Highlighting its Next-Generation ADC Portfolio at the AACR 2026
Apr 10 2026
Whitehawk Therapeutics Presents Real-World Analysis Confirming MUC16 as a Highly Expressed, Clinically Relevant Target for Gynecologic Cancers at SGO 2026
Mar 17 2026
Whitehawk Therapeutics to Highlight its Next-Generation ADC Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026
Mar 12 2026
Whitehawk Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights
Feb 18 2026
Whitehawk Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

Community Chat

Ask AI

6ix6ix